eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
Glycolysis↓, ROS↑, GPx↓, eff↓, OXPHOS↓, HK2↓, ATP↓, ROS↑, ER Stress↑, BioAv↓, Cyt‑c↑, eff↑,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
Nor, |
L02 |
|
|
|
tumCV↓, ROS↑, *ROS↑, DNAdam↑, *DNAdam↑, eff↓, selectivity↑,
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
BT549 |
|
|
|
- |
in-vivo, |
BC, |
MDA-MB-231 |
|
|
|
ROS↑, DNAdam↑, selectivity↑, TumCG↓, RadioS↑, Dose↝, selectivity↑, other↝, eff↓, eff↑, γH2AX↑, Dose↓, eff↑,
*TumCP↓, *ROS↑, *eff↓, *MDA↑, *GSH↓, *MMP↓, *ATP↓, *LC3II↑, *p62↑, *Bcl-2↓, *BAX↑, *Casp3↑,
*BioAv↝, *eff↓, *BioAv↝, *BioAv↝, *eff↑, *Half-Life∅, *eff↑, *eff↑, *Dose∅, *eff↑,
| - |
in-vitro, |
Nor, |
HDFa |
|
|
|
- |
in-vitro, |
PC, |
AsPC-1 |
|
|
|
- |
in-vitro, |
PC, |
MIA PaCa-2 |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Pca, |
LNCaP |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
selectivity↑, selectivity↑, selectivity↓, ROS↑, eff↑, tumCV↓, MMP↓, Dose∅, eff↓, DNAdam↑, Apoptosis↑, TumAuto↑, Necroptosis↑, p‑P53↑, BIM↑, BAX↑, p‑PARP↑, Casp3↑, Casp8↑, Casp9↑, Cyt‑c↑, Bcl-2↓, AIF↑, p62↑, LC3B↑, MLKL↑, p‑MLKL↓, RIP3↑, p‑RIP3↑, TumCG↑, TumW↓,
| - |
Review, |
BC, |
MCF-7 |
|
|
|
- |
NA, |
BC, |
MDA-MB-231 |
|
|
|
- |
NA, |
Nor, |
HMEC |
|
|
|
Apoptosis↑, ROS↑, DNAdam↑, OXPHOS↓, *ROS∅, Bcl-2↓, XIAP↓, survivin↓, DR5↑, IKKα↓, NF-kB↓, selectivity↑, *ROS∅, eff↓, Paraptosis↑,
| - |
in-vitro, |
BrCC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
tumCV↓, i-ROS↑, MMP↓, Bcl-2↓, BAX↑, Cyt‑c↑, Casp9↑, Casp3↑, eff↓, selectivity↑, *toxicity∅, Apoptosis↑, Fenton↑,
| - |
in-vitro, |
OS, |
MG63 |
|
|
|
- |
in-vitro, |
Nor, |
hFOB1.19 |
|
|
|
TumCD↑, Apoptosis↑, ROS↑, eff↓, Casp3↑, Bcl-2↓, selectivity↑, Cyt‑c↑, LDH?, BNIP3?, BAX↑,
*P-gp↓, *NF-kB↑, *eff↓, *Dose↝,
| - |
in-vitro, |
HCC, |
HepG2 |
|
|
|
- |
in-vitro, |
Nor, |
HL7702 |
|
|
|
TumCCA↑, SLC12A5↓, ATF6↑, CHOP↑, GRP78/BiP↑, Casp3↑, ER Stress↝, *toxicity↓, *eff↓,
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Nor, |
SV-HUC-1 |
|
|
|
- |
in-vitro, |
Bladder, |
5637 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
HDAC↓, AntiTum↑, TumCMig↓, AMPK↑, mTOR↑, TumAuto↑, ROS↑, miR-139-5p↑, BMI1↓, TumCI?, E-cadherin↑, N-cadherin↓, Vim↓, Snail↓, cl‑PARP↑, cl‑Casp3↑, BAX↑, Bcl-2↓, Bcl-xL↓, MMP↓, PINK1↑, PARK2↑, TumMeta↓, TumCG↓, LC3II↑, p62↓, eff↓,
| - |
vitro+vivo, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
BEAS-2B |
|
|
|
- |
in-vitro, |
Lung, |
PC9 |
|
|
|
Dose↝, mt-ROS↑, p‑JNK↑, BAX↑, Cyt‑c↑, Casp↑, AntiTum↑, ER Stress↑, LDH↑, selectivity↑, Apoptosis↑, DNAdam↑, IRE1↑, XBP-1↑, CHOP↓, p‑eIF2α↓, GRP78/BiP↓, Ca+2↑, MMP↓, Bcl-2↓, Casp3↑, Casp9↑, eff↓, TumW↓, Weight↑, eff↑, eff↑,
*toxicity↓, *antiOx↑, *Bacteria↓, *AntiDiabetic↑, *neuroP↑, *Inflam↓, *cardioP↑, *BP↓, *other↓, eff↓,
| - |
in-vitro, |
Ovarian, |
SKOV3 |
|
|
|
- |
in-vitro, |
Ovarian, |
A2780S |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
Apoptosis↑, Ferroptosis↑, Ca+2↓, CaMKII
↓, Akt↓, mTOR↓, Hif1a↓, ROS↑, ChemoSen↑, Casp3↑, Casp9↑, BAX↑, Bcl-2↓, Cyt‑c↑, GlucoseCon↓, lactateProd↓, Pyruv↓, GLUT1↓, HK2↓, PFKP↓, Glycolysis↓, Hif1a↓, p‑Akt↓, p‑mTOR↓, Iron↑, lipid-P↑, MDA↑, ROS↑, H2O2↑, mtDam↑, GSH↓, GPx↓, GPx4↓, NADPH/NADP+↓, eff↓, FTH1↓, LC3‑Ⅱ/LC3‑Ⅰ↑, NCOA4↑, eff↓, TumCG↓,
*SCD1↓, *Weight↓, *Insulin↓, *IGF-1↓, *adiP↑, *eff↓,
*ROS↓, eff↓,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
Apoptosis↑, *toxicity↓, *eff↓,
| - |
in-vitro, |
CLL, |
KBM-5 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
Apoptosis↑, ChemoSen↑, IAP1↓, IAP2↓, Bcl-2↓, Bcl-xL↓, TRAF1↓, cycD1/CCND1↓, cMyc↓, COX2↓, MMP9↓, angioG↓, VEGF↓, NF-kB↓, eff↓,
| - |
in-vitro, |
Nor, |
MCF10 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-435 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-468 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
Paraptosis↑, ER Stress↑, MMP↓, eff↓, selectivity↑, p‑ERK↑, p‑JNK↑, eff↓,
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
Casp3↑, Casp9↑, Casp8↑, DR5↑, survivin↓, Bcl-2↓, XIAP↓, cFLIP↓, BAX↑, Cyt‑c↑, ROS↑, GSH↓, *eff↓,
| - |
in-vitro, |
Nor, |
MCF10 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-468 |
|
|
|
- |
in-vitro, |
PC, |
Bxpc-3 |
|
|
|
TumCP↓, Apoptosis↑, eff↓, *toxicity↑, Dose?, eff↓, eff↓,
*Ca+2↓, *eff↓, *ROS↓,
*MPT↑, *Cyt‑c↑, *ROS↑, *p‑GSK‐3β↑, *eff↓, *MMP∅, *BAX↓, *Bcl-2∅,
*mt-OCR↑, *mt-ROS↑, *ECAR↑, *Dose↝, *Ca+2↑, *ATP↑, *other↑, *eff↓, *eff↝,
| - |
in-vitro, |
GBM, |
GBM |
|
|
|
- |
in-vitro, |
Nor, |
SVGp12 |
|
|
|
TumVol↓, OS↑, γH2AX↑, DNAdam↑, selectivity↑, ROS↑, TumCD↑, eff↑, eff↓,
| - |
in-vitro, |
PC, |
PANC1 |
|
|
|
- |
in-vitro, |
Nor, |
H6c7 |
|
|
|
tumCV↓, ROS↑, eff↑, Dose∅, selectivity↑, MMP↓, mtDam↑, cl‑PARP↑, p‑ERK↓, p‑JNK↑, p‑p38↑, eff↓, ChemoSen↑,
Dose∅, Dose∅, eff↓, antiOx↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Nor, |
HaCaT |
|
|
|
DNAdam↑, Apoptosis↑, ChemoSen↑, ROS↑, mt-ROS↑, Casp↑, Casp3↑, selectivity↑, TumCP↓, tumCV↓, eff↓,
*ROS↑, *GSH↓, *SOD↓, *Catalase↓, eff↓,
*BioAv↓, *BioAv↑, *other↝, *eff↓,
| - |
in-vitro, |
OS, |
MG63 |
|
|
|
- |
in-vitro, |
Nor, |
hFOB1.19 |
|
|
|
tumCV↓, selectivity↑, mtDam↑, Ca+2↓, ER Stress↑, ROS↑, Casp3↑, Casp9↑, Apoptosis↑, eff↓,
| - |
in-vivo, |
Nor, |
EL4 |
|
|
|
- |
in-vitro, |
AML, |
Jurkat |
|
|
|
JNK↑, Cyt‑c↑, FasL↑, BAX↑, ROS↑, *ROS↑, MKP1↓, MKP2↓, selectivity∅, tumCV↑, Cyt‑c↑, Casp3↑, GSH/GSSG↓, ROS↑, mt-ROS↑, *ROS↑, eff↓,
*MitoP↑, *NRF2↑, eff↑, *eff↓, *GutMicro↑,
eff↑, eff↓,
eff↑, eff↓,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Nor, |
1321N1 |
|
|
|
*ROS↓, *BioAv↑, LC3II↑, LAMP1?, TumAuto↑, TFEB↑, ROS↑, eff↓,
*CardioT↓, *NRF2↑, *eff↓, *ROS↓,
| - |
in-vitro, |
OS, |
143B |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
- |
in-vivo, |
OS, |
NA |
|
|
|
AntiCan↑, *toxicity∅, Ferroptosis↑, ROS↑, lipid-P↑, GSH↓, p62↑, SLC12A5↓, eff↓, GPx4↓, i-Iron↑, eff↓, MDA↑, TumVol↓, TumW↓, Ki-67↓, LC3B↑, *Weight∅,
| - |
in-vitro, |
GC, |
BGC-823 |
|
|
|
- |
in-vitro, |
GC, |
SGC-7901 |
|
|
|
- |
in-vitro, |
Nor, |
GES-1 |
|
|
|
selectivity↑, TumCP↓, TumCD↑, ROS↑, MMP↓, Casp↑, Cyt‑c↑, Endon↑, AIF↑, eff↓, ChemoSen↑, TumCCA↑, GSH/GSSG↓, lipid-P↑,
| - |
in-vivo, |
Nor, |
NA |
|
|
|
- |
in-vitro, |
Nor, |
HK-2 |
|
|
|
*ER Stress↓, *SIRT1↑, *NRF2↑, *HO-1↑, *eff↓, *RenoP↑, *GRP78/BiP↓, *CHOP↓, *Casp12↓, *BAX↓, *cl‑Casp3↓,
*cardioP↑, *ROS↓, *Inflam↓, *Mst1↓, *NRF2↑, *eff↓, *antiOx↑, *SOD↑, *GSH↑, *TNF-α↓, BAX↓, Bcl-2↑,
| - |
in-vitro, |
Lung, |
H1975 |
|
|
|
- |
in-vitro, |
Lung, |
H1650 |
|
|
|
- |
in-vitro, |
Nor, |
CCD19 |
|
|
|
EGFR↓, selectivity↑, Casp↑, PARP↑, Apoptosis↑, ROS↑, eff↓, selectivity↑,
cardioP↑, eff↓, AntiAge↑, BioAv↑, CRM↝,
| - |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
CRC, |
HT-29 |
|
|
|
- |
in-vitro, |
Nor, |
SVGp12 |
|
|
|
Ferroptosis↑, xCT↓, GSH↓, GPx4↓, Iron↑, lipid-P↑, ROS↑, eff↓, TumCP↓, TumCD↑,
*HO-1↑, *NRF2↑, *e-ERK↑, *e-Akt↑, *AMPKα↑, *ROS⇅, *eff↓, *tumCV∅,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Bladder, |
J82 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
- |
in-vitro, |
Nor, |
L02 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
MMP↓, Cyt‑c↑, Casp3↑, p‑JNK↑, p‑p38↑, ROS↑, eff↓, tumCV↓, selectivity↑, *toxicity↓, TumVol↓,
Showing Research Papers: 1 to 47 of 47
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 47
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, Fenton↑, 1, Ferroptosis↑, 3, GPx↓, 2, GPx4↓, 3, GSH↓, 4, GSH/GSSG↓, 2, H2O2↑, 1, Iron↑, 2, i-Iron↑, 1, lipid-P↑, 4, MDA↑, 2, NADPH/NADP+↓, 1, OXPHOS↓, 2, PARK2↑, 1, ROS↑, 23, i-ROS↑, 1, mt-ROS↑, 3, xCT↓, 1,
Metal & Cofactor Biology ⓘ
FTH1↓, 1, NCOA4↑, 1,
Mitochondria & Bioenergetics ⓘ
AIF↑, 2, ATP↓, 1, MMP↓, 8, mtDam↑, 3, PINK1↑, 1, XIAP↓, 2,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, cMyc↓, 1, CRM↝, 1, GlucoseCon↓, 1, Glycolysis↓, 2, HK2↓, 2, lactateProd↓, 1, LDH?, 1, LDH↑, 1, PFKP↓, 1, Pyruv↓, 1,
Cell Death ⓘ
Akt↓, 1, p‑Akt↓, 1, Apoptosis↑, 12, BAX↓, 1, BAX↑, 8, Bcl-2↓, 9, Bcl-2↑, 1, Bcl-xL↓, 2, BIM↑, 1, Casp↑, 4, Casp3↑, 11, cl‑Casp3↑, 1, Casp8↑, 2, Casp9↑, 6, cFLIP↓, 1, Cyt‑c↑, 11, DR5↑, 2, Endon↑, 1, FasL↑, 1, Ferroptosis↑, 3, IAP1↓, 1, IAP2↓, 1, JNK↑, 1, p‑JNK↑, 4, MKP1↓, 1, MKP2↓, 1, MLKL↑, 1, p‑MLKL↓, 1, Necroptosis↑, 1, p‑p38↑, 2, Paraptosis↑, 2, survivin↓, 2, TumCD↑, 4,
Kinase & Signal Transduction ⓘ
CaMKII
↓, 1,
Transcription & Epigenetics ⓘ
other↝, 1, tumCV↓, 7, tumCV↑, 1,
Protein Folding & ER Stress ⓘ
ATF6↑, 1, CHOP↓, 1, CHOP↑, 1, p‑eIF2α↓, 1, ER Stress↑, 4, ER Stress↝, 1, GRP78/BiP↓, 1, GRP78/BiP↑, 1, IRE1↑, 1, XBP-1↑, 1,
Autophagy & Lysosomes ⓘ
BNIP3?, 1, LC3‑Ⅱ/LC3‑Ⅰ↑, 1, LC3B↑, 2, LC3II↑, 2, p62↓, 1, p62↑, 2, TFEB↑, 1, TumAuto↑, 3,
DNA Damage & Repair ⓘ
DNAdam↑, 7, p‑P53↑, 1, PARP↑, 1, p‑PARP↑, 1, cl‑PARP↑, 2, γH2AX↑, 2,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
BMI1↓, 1, p‑ERK↓, 1, p‑ERK↑, 1, HDAC↓, 1, mTOR↓, 1, mTOR↑, 1, p‑mTOR↓, 1, TumCG↓, 3, TumCG↑, 1,
Migration ⓘ
Ca+2↓, 2, Ca+2↑, 1, E-cadherin↑, 1, Ki-67↓, 1, LAMP1?, 1, miR-139-5p↑, 1, MMP9↓, 1, N-cadherin↓, 1, RIP3↑, 1, p‑RIP3↑, 1, Snail↓, 1, TumCI?, 1, TumCMig↓, 1, TumCP↓, 4, TumMeta↓, 1, Vim↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, EGFR↓, 1, Hif1a↓, 2, VEGF↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 1, SLC12A5↓, 2,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, IKKα↓, 1, NF-kB↓, 2, TRAF1↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 1, ChemoSen↑, 5, Dose?, 1, Dose↓, 1, Dose↝, 2, Dose∅, 4, eff↓, 36, eff↑, 11, RadioS↑, 1, selectivity↓, 1, selectivity↑, 18, selectivity∅, 1,
Clinical Biomarkers ⓘ
EGFR↓, 1, Ki-67↓, 1, LDH?, 1, LDH↑, 1,
Functional Outcomes ⓘ
AntiAge↑, 1, AntiCan↑, 1, AntiTum↑, 2, cardioP↑, 1, OS↑, 1, TumVol↓, 3, TumW↓, 3, Weight↑, 1,
Total Targets: 161
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, Catalase↓, 1, GSH↓, 2, GSH↑, 1, HO-1↑, 2, MDA↑, 1, NRF2↑, 5, ROS↓, 5, ROS↑, 6, ROS⇅, 1, ROS∅, 2, mt-ROS↑, 1, SOD↓, 1, SOD↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, ATP↑, 1, Insulin↓, 1, MMP↓, 1, MMP∅, 1, MPT↑, 1, mt-OCR↑, 1,
Core Metabolism/Glycolysis ⓘ
adiP↑, 1, ECAR↑, 1, SCD1↓, 1, SIRT1↑, 1,
Cell Death ⓘ
e-Akt↑, 1, BAX↓, 2, BAX↑, 1, Bcl-2↓, 1, Bcl-2∅, 1, Casp12↓, 1, Casp3↑, 1, cl‑Casp3↓, 1, Cyt‑c↑, 1,
Kinase & Signal Transduction ⓘ
AMPKα↑, 1,
Transcription & Epigenetics ⓘ
other↓, 1, other↑, 1, other↝, 1, tumCV∅, 1,
Protein Folding & ER Stress ⓘ
CHOP↓, 1, ER Stress↓, 1, GRP78/BiP↓, 1,
Autophagy & Lysosomes ⓘ
LC3II↑, 1, MitoP↑, 1, p62↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1,
Proliferation, Differentiation & Cell State ⓘ
e-ERK↑, 1, p‑GSK‐3β↑, 1, IGF-1↓, 1, Mst1↓, 1,
Migration ⓘ
Ca+2↓, 1, Ca+2↑, 1, TumCP↓, 1,
Barriers & Transport ⓘ
P-gp↓, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 2, NF-kB↑, 1, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 2, BioAv↝, 3, Dose↝, 2, Dose∅, 1, eff↓, 16, eff↑, 4, eff↝, 1, Half-Life∅, 1,
Clinical Biomarkers ⓘ
BP↓, 1, GutMicro↑, 1,
Functional Outcomes ⓘ
AntiDiabetic↑, 1, cardioP↑, 2, CardioT↓, 1, neuroP↑, 1, RenoP↑, 1, toxicity↓, 4, toxicity↑, 1, toxicity∅, 2, Weight↓, 1, Weight∅, 1,
Infection & Microbiome ⓘ
Bacteria↓, 1,
Total Targets: 79
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:961 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page